top of page
EB3019 phosphate salt (5 mg)
IUPAC: N,N-Dibutyl-5-[4-(butylamino)-3-methylphenyl]-1,2,4-oxadiazole-3-methanamine di-phosphate
 
Chemical Formula: C14H31N3O9P2
 
Molecular Weight: 449.36
 
H-NMR and C-NMR are provided upon request.
 
All chemicals supplied by Captis Biotech are intended exclusively for research purposes and are not suitable for human consumption. Purchasers must be affiliated with an industry or academic institution and must provide verifiable proof of affiliation prior to purchase approval.

EB3019 phosphate salt (5 mg)

SKU: 0000226
$125.00Price

  • This compound was identified as a promising lead compound for the treatment of CPVT, with a favorable pharmacokinetic profile. The compound normalized aberrant RyR2 activity in vitro and in vivo, without altering cardiac inotropy or chronotropy.

    This compound is part of a focused library for the development of drugs for the treatment of CPVT (Catecholaminergic Polymorphic Ventricular Tachycardia) and other related cardiovascular diseases. This library contains compounds with different scaffolds that incorporate structural features associated with RyR2 inhibitory activity.

bottom of page